Transplacental treatment of foetal supraventricular tachycardia with triple antiarrhythmic combination to avoid intra-foetal intervention

Although a high percentage of foetuses with supraventricular tachycardia respond to single or dual antiarrhythmic therapy, on occasion when there is no response to these combination regimens, direct intra-foetal therapy remains the only choice, albeit such an approach carries a potential risk to the...

Full description

Saved in:
Bibliographic Details
Published in:Cardiology in the young 2022-07, Vol.32 (7), p.1162-1165
Main Authors: Babaoglu, Kadir, Dogan, Yasemin, Uzun, Orhan
Format: Article
Language:English
Subjects:
Antiarrhythmics
Arrhythmia
Brief Report
Cardiac arrhythmia
Drug dosages
Electrocardiography
Fetal Cardiology
Fetuses
Heart rate
Sinuses
Tachycardia
Therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although a high percentage of foetuses with supraventricular tachycardia respond to single or dual antiarrhythmic therapy, on occasion when there is no response to these combination regimens, direct intra-foetal therapy remains the only choice, albeit such an approach carries a potential risk to the foetus. Data with regard to the safety and efficacy of triple antiarrhythmic combination have not been reported before. Here, we present a foetus with intractable tachycardia in whom arrhythmia termination was successfully achieved with triple oral antiarrhythmic therapy.
ISSN:1047-9511
1467-1107
DOI:10.1017/S1047951121004595